ba0007p142 | (1) | ICCBH2019
Soerensen TH
, Granild-Jensen Jakob Bie
, Vestergaard Esben Thyssen
, Rackauskaite Gija
, Soendergaard Charlotte
, Farholt Stense
, Moller-Madsen Bjarne
, Langdahl Bente
Objectives: Low bone mineral density is highly prevalent in non-ambulant cerebral palsy and is associated with a high risk of fractures. In most cases these fractures occur with no or minimal trauma. Primary and secondary fracture prevention strategies differ between sites and countries. In order to inform these strategies we intend to complete a trial of Zoledronate in children with Cerebral Palsy. We hypothesize that Zoledronate treatment significantly increases bone mineral...